Fresenius SE & Co KGaA (FREG.DE)
96.33EUR
11:35am EDT
€1.45 (+1.53%)
€96.88
€94.53
€97.15
€94.53
389,935
415,113
€100.10
€81.83
About
Overall
| Beta: | 0.46 |
| Market Cap (Mil.): | €16,929.72 |
| Shares Outstanding (Mil.): | 178.43 |
| Dividend: | 1.10 |
| Yield (%): | 1.16 |
Financials
| FREG.DE | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 18.41 | 66.39 | 37.76 |
| EPS (TTM): | 5.15 | -- | -- |
| ROI: | 9.22 | 4.99 | 18.76 |
| ROE: | 12.67 | 9.80 | 19.59 |
UPDATE 1-Fresenius hikes profit outlook on strong hospitals unit
* FMC unit Q2 net misses market view on U.S. healthcare cuts (Adds background on hospitals business, FMC unit results)
Rhoen-Klinikum shareholder files case against AGM vote
FRANKFURT - B. Braun Holding, an investor in Rhoen-Klinikum , said it had filed a case on Tuesday contesting a shareholder vote to remove a barrier to the German hospital operator being taken over.
UPDATE 1-China probes pricing at drugmakers including GSK, Merck
* Top agency to review costs, prices at dozens of drugmakers
Falls at Fresenius and Danone push back Europe shares
LONDON, July 2 - Medical group Fresenius and food group Danone weighed on European shares on Tuesday, with traders expecting little near-term progress for European equities.
Falls at Fresenius, Danone weigh on Europe shares
LONDON, July 2 - Falls at medical group Fresenius and food group Danone weighed on European shares on Tuesday, with traders expecting the near-term trend for European equities to remain a relatively negative one.
Fresenius sells biotech unit
FRANKFURT, June 28 - Germany's Fresenius said it has sold its biotechnology business to the owners of Neopharm, Israel's second largest pharma company, as it focuses on the other parts of its business that it sees as offering better opportunities.
RPT-Fitch Affirms Fresenius at 'BB+'; Outlook Revised to Positive
June 17 - (The following statement was released by the rating agency)
Rhoen says renewed takeover attempt not a given
FRANKFURT, June 13 - Rhoen-Klinikum cautioned that a shareholder vote that removed a major barrier against a takeover of the German hospital operator would not necessarily lead to a new bid from one-time suitor Fresenius .
UPDATE 1-Rhoen shareholders vote to scrap takeover hurdle
* Removal of hurdle could lure back one-time bidder Fresenius
Fresenius eyes more hospital deals in Germany
FRANKFURT, May 17 - German diversified healthcare group Fresenius will look for further takeovers to underpin its position as Germany's largest private-sector hospitals operator, its chief executive said.
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Finlabo SIM Spa
|
$10.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: GlobalData
|
$250.00
|
|
Provider: Wright Reports
|
$495.00
|
|
Provider: Datamonitor
|
$175.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

